2000Journal of Ningbo UniversityRequires access

Exploring dosage of sotalol on arrhythmia

Hong Zhong-li

Open publisher page 0 citations

Abstract

Objective: To detect the efficacy and optimal dosage of sotalol on arrhythmia. Methods: 53 patients with non-myocardial infarction receiving sotalol with different string-does, were evaluated by clinic and 24-hour Holier monitoring. Results: (1) In all 53 patients, 39 cases were efficiency, the total effective rate was 73.58%. (2)In 39 efficacy cases, the average does was 93.57mg/d. (3)After oral low-does sotalol, QTc interval increased from (0.39±0.03) s to (0.41±0.03) s (0.01P0.05), HR decreased from (79.39±13.85) beats/min to (64.11 ± 8.19) beats/min(P0.01) But BP had no significant difference. (4) There were 9 cases had side effects, but all were alleviated by decreasing the dosage. No torsade de pointes. Conclusion: Sotalol was efficiency in treatment of supraventricular or ventricular arrhythmia.Its average efficient dose was low and its side effect was seldom. So it would become a better antiarrhythmic drug in future.

About this research paper

What this paper is about

Objective: To detect the efficacy and optimal dosage of sotalol on arrhythmia. Methods: 53 patients with non-myocardial infarction receiving sotalol with different string-does, were evaluated by clinic and 24-hour Holier monitoring. Results: (1) In all 53 patients, 39 cases were efficiency, the total effective rate was 73.58%. (2)In 39 efficacy cases, the average does was 93.57mg/d. (3)After oral low-does sotalol, QTc interval increased from (0.39±0.03) s to (0.41±0.03) s (0.01P0.05), HR decreased from (79.39±13.85) beats/min to (64.11 ± 8.19) beats/min(P0.01) But BP had no significant difference. (4) There were 9 cases had side effects, but all were alleviated by decreasing the dosage. No torsade de pointes. Conclusion: Sotalol was efficiency in treatment of supraventricular or ventricular arrhythmia.Its average efficient dose was low and its side effect was seldom. So it would become a better antiarrhythmic drug in future.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To detect the efficacy and optimal dosage of sotalol on arrhythmia. Methods: 53 patients with non-myocardial infarction receiving sotalol with different string-does, were evaluated by clinic and 24-hour Holier monitoring. Results: (1) In all 53 patients, 39 cases were efficiency, the total effective rate was 73.58%. (2)In 39 efficacy cases, the average does was 93.57mg/d. (3)After oral low-does sotalol, QTc interval increased from (0.39±0.03) s to (0.41±0.03) s (0.01P0.05), HR decreased from (79.39±13.85) beats/min to (64.11 ± 8.19) beats/min(P0.01) But BP had no significant difference. (4) There were 9 cases had side effects, but all were alleviated by decreasing the dosage. No torsade de pointes. Conclusion: Sotalol was efficiency in treatment of supraventricular or ventricular arrhythmia.Its average efficient dose was low and its side effect was seldom. So it would become a better antiarrhythmic drug in future.

Key concepts: Sotalol, Medicine, Supraventricular arrhythmia, QT interval, Cardiology, Myocardial infarction, Anesthesia, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Exploring dosage of sotalol on arrhythmia — Research Paper | ScholarLens